Overview: pharmacokinetic drug-drug interactions.
Li
A P
AP
In Vitro Technologies, Inc., University of Maryland Technology Center, Baltimore 21227, USA.
Jurima-Romet
M
M
D001086:Arabinofuranosyluracil / Q000009:adverse effects / Q000031:analogs & derivatives; D003276:Contraceptives, Oral; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis / Q000378:metabolism*; D004347:Drug Interactions; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism*; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D010599:Pharmacokinetics; D011247:Pregnancy; D011275:Pregnancy, Unwanted; D016593:Terfenadine / Q000009:adverse effects
D003276:Contraceptives, Oral; D065607:Cytochrome P-450 Enzyme Inhibitors; D007527:Isoenzymes; D001086:Arabinofuranosyluracil; D016593:Terfenadine; D003577:Cytochrome P-450 Enzyme System; C031368:sorivudine